Correlation between chemotherapy response score (CRS) and germline BRCA1/2 (gBRCA) status in women diagnosed with FIGO stage IIIC/IV high-grade serous ovarian cancer (HGSOC)

被引：0
|
作者：
Netto, D. [1 ]
Wang, X. [2 ]
Barnes, B. [3 ]
Clamp, A. R. [1 ]
Hasan, J. [1 ]
Mitchell, C. L. [1 ]
Salih, Z. [1 ]
Winter-Roach, B. [4 ]
Edmondson, R. [3 ]
Shaw, J. [5 ]
Desai, S. [6 ]
Schlecht, H. [7 ]
Burghel, G. J. [8 ]
Taylor, S. [9 ]
Evans, G. [10 ]
Jayson, G. C. [11 ]
Morgan, R. D. [1 ]
机构：
[1] Christie NHS Fdn Trust, Med Oncol Dept, Manchester, Lancs, England
[2] Christie NHS Fdn Trust, Stat, Manchester, Lancs, England
[3] Univ Manchester, Div Canc Sci, Manchester, Lancs, England
[4] Christie NHS Fdn Trust, Surg Oncol, Manchester, Lancs, England
[5] Manchester Univ NHS Fdn Trust, Histopathol, Manchester, Lancs, England
[6] Christie NHS Fdn Trust, Pathol, Manchester, Lancs, England
[7] Manchester Univ NHS Fdn Trust, Genom, Wythenshawe Hosp, Manchester, Lancs, England
[8] GLH North West Genom Lab Hub, North West Genom Lab Hyb, Manchester, Lancs, England
[9] Univ Manchester, Manchester Canc Res Ctr, Manchester, Lancs, England
[10] Manchester Univ NHS Fdn Trust, Clin Genet, Manchester, Lancs, England
[11] Univ Manchester, Med Oncol, Manchester, Lancs, England
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.1960
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
782P
引用
收藏
页码：S527 / S528
页数：2
相关论文
共 50 条
  • [1] Association between chemotherapy response score (CRS) and tumour homologous recombination deficiency (tHRD) in women with newly diagnosed FIGO stage IIIC/IV high-grade serous ovarian cancer (HGSOC)
    Britton, F.
    Zhou, C.
    Burghel, G. J.
    Schlecht, H.
    Desai, S.
    Barnes, B.
    Clamp, A. R.
    Hasan, J.
    Mitchell, C. L.
    Salih, Z.
    Edmondson, R.
    Evans, G. D.
    Jayson, G. C.
    Taylor, S.
    Morgan, R. D.
    ANNALS OF ONCOLOGY, 2024, 35 : S584 - S584
  • [2] Germline BRCA1/2 status and chemotherapy response score in high-grade serous ovarian cancer
    Morgan, Robert D.
    Wang, Xin
    Barnes, Bethany M.
    Spurgeon, Laura
    Carrot, Aurore
    Netto, Daniel
    Hasan, Jurjees
    Mitchell, Claire
    Salih, Zena
    Desai, Sudha
    Shaw, Joseph
    Winter-Roach, Brett
    Schlecht, Helene
    Burghel, George J.
    Clamp, Andrew R.
    Edmondson, Richard J.
    You, Benoit
    Evans, D. Gareth R.
    Jayson, Gordon C.
    Taylor, Stephen S.
    BRITISH JOURNAL OF CANCER, 2024, 131 (12) : 1919 - 1927
  • [3] BRCA1 methylation status in high-grade serous ovarian cancer (HGSOC) patients (pts).
    Ruscito, Ilary
    Braicu, Elena Ioana
    Panici, Pierluigi Benedetti
    Chekerov, Radoslav
    Dimitrova, Desislava
    Ganapathi, Ram N.
    Vasconcelos, Ines
    Bellati, Filippo
    Fotopoulou, Christina
    Lichtenegger, Werner
    Olek, Sven
    Sehouli, Jalid
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [4] Distinct immune characteristics in women with deleterious germline BRCA1/2 mutations (gBRCAm)-associated high-grade serous ovarian cancer (HGSOC)
    Lee, J. M.
    Tomita, Y.
    Chiou, V.
    Lee, S.
    Yu, M.
    Houston, N.
    Lee, M. J.
    Kohn, E. C.
    Trepel, J.
    GYNECOLOGIC ONCOLOGY, 2015, 137 : 44 - 44
  • [5] BRCA1 expression, its correlation with clinicopathological features, and response to neoadjuvant chemotherapy in high-grade serous ovarian cancer
    Patil, Akkamahadevi
    Patil, Sharada
    Anupama, C. E.
    Rajarajan, Savitha
    Nimbalkar, Vidya P.
    Amirtham, Usha
    Champaka, G.
    Suma, M. N.
    Patil, Geetha V.
    Nargund, Ashwini
    Pallavi, V. R.
    Jacob, Linu
    Premalatha, C. S.
    Prabhu, Jyothi S.
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2023, 49 (12) : 2875 - 2882
  • [6] Mutation landscape of germline and somatic BRCA1/2 in patients with high-grade serous ovarian cancer
    Kyung Jin Eoh
    Hye Min Kim
    Jung-Yun Lee
    Sunghoon Kim
    Sang Wun Kim
    Young Tae Kim
    Eun Ji Nam
    BMC Cancer, 20
  • [7] Mutation landscape of germline and somatic BRCA1/2 in patients with high-grade serous ovarian cancer
    Eoh, Kyung Jin
    Kim, Hye Min
    Lee, Jung-Yun
    Kim, Sunghoon
    Kim, Sang Wun
    Kim, Young Tae
    Nam, Eun Ji
    BMC CANCER, 2020, 20 (01)
  • [8] Tissue is the issue: Chemotherapy response score (CRS) is most predictive of response to neoadjuvant chemotherapy in advanced, high grade serous ovarian cancer (HGSOC)
    Knickerbocker, Abbey
    Kuchta, Kristine
    Donaldson, Carolyn
    Moore, Elena Diaz
    Lippitt, Melissa
    Rodriguez, Gustavo
    Watkin, William
    Vogel, Tilley Jenkins
    GYNECOLOGIC ONCOLOGY, 2022, 166 : S241 - S242
  • [9] Tissue is the issue: chemotherapy response score (CRS) is most predictive of response to neoadjuvant chemotherapy in advanced, high grade serous ovarian cancer (HGSOC)
    Knickerbocker, Abbey
    Kuchta, Kristine
    Donaldson, Carolyn
    Moore, Elena Diaz
    Lippitt, Melissa
    Rodriguez, Gustavo
    Watkin, William
    Vogel, Tilley Jenkins
    GYNECOLOGIC ONCOLOGY, 2022, 165 : S10 - S11
  • [10] Evaluation of telephone genetic counselling to facilitate germline BRCA1/2 testing in women with high-grade serous ovarian cancer
    Tutty, Erin
    Petelin, Lara
    McKinley, Joanne
    Young, Mary-Anne
    Meiser, Bettina
    Rasmussen, Victoria M.
    Forbes Shepherd, Rowan
    James, Paul A.
    Forrest, Laura E.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2019, 27 (08) : 1186 - 1196
12345